Researchers say a new drug for breast cancer will give patients vital extra time.
The drug called Kadcyla was trialled in Manchester and is now available to patients for the first time.
Doctors say it can extend women's lives by almost six months for those with the most aggressive form of the disease.
Around thirteen hundred women in England could benefit from the drug, which costs £6,000 a month.
Mel Barham reports
More top news
Cold and blustery with clear spells and wintry showers. Risk of ice and snow cover over hills by dawn on Monday
Windy. Wintry showers, giving snowfall over hills and ice risk.
Showers turning increasingly wintry after dusk. Snow may settle over higher routes by dawn. Risk of ice for the Monday rush hour